Mechanosynthesis of urea-hydroxybenzoic acid cocrystals as sustained-release nitrogen fertilizer

被引:6
|
作者
Rajbongshi, Trishna [1 ]
Parakatawella, Shalika [2 ]
Gogoi, Diptajyoti [1 ]
Deka, Poonam [1 ]
Adassooriya, Nadeesh M. [3 ]
Thakuria, Ranjit [1 ]
机构
[1] Gauhati Univ, Dept Chem, Gauhati 781014, Assam, India
[2] Univ Peradeniya, Postgrad Inst Sci, Peradeniya 20400, Sri Lanka
[3] Univ Peradeniya, Fac Engn, Dept Chem & Proc Engn, Peradeniya 20400, Sri Lanka
来源
RSC SUSTAINABILITY | 2023年 / 1卷 / 06期
关键词
SLOW-RELEASE; SOLUBILITY; CRYSTAL; MIGRATION; MAGNESIUM; THIOUREA; COMPLEX; PROTON;
D O I
10.1039/d3su00021d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nitrogen is a key nutrient source in agriculture, which has a crucial impact on crop productivity. Out of available nitrogen fertilizers, urea is identified as the major nitrogen source, accounting for similar to 60% of global use. However, due to the low nutrient usage efficiency of urea, it has become unsustainable, as 50-70% nitrogen applied is lost due to leaching, volatilization and nitrification, causing a series of environmental hazards and economic losses. Moreover, the recent global pandemic as well as war disrupt the food supply chain and fertilizer market. Here we used mechanochemistry to prepare a series of novel urea cocrystals that showed sustained-release behavior with significant improvement (similar to 4 times), lower volatilization, and improved hydration stability compared to commercial urea. Therefore, the proposed urea cocrystal based fertilizer system demonstrates a potential sustained-release nitrogen source in agriculture where excessive use of fertilizer and nutrient loss can be minimised. Mechanosynthesis of urea hydroxybenzoic acid cocrystals/salt showed improved hydration stability and sustained-release behavior. Therefore, cocrystallisation of urea can be considered as a potential tool to minimize its excessive use.
引用
收藏
页码:1416 / 1422
页数:7
相关论文
共 50 条
  • [41] THE RELEASE PROFILE OF A SUSTAINED-RELEASE PREPARATION OF 5'-AMINOSALICYLIC ACID (ROWASA) IN THE SMALL-BOWEL
    MCLEOD, RS
    COHEN, Z
    VARI, BJ
    BLAIR, JE
    GASTROENTEROLOGY, 1986, 90 (05) : 1546 - 1546
  • [42] Release performance and sustained-release efficacy of emamectin benzoate-loaded polylactic acid microspheres
    YIN Ming-ming
    ZHU Xin-yan
    CHEN Fu-liang
    JournalofIntegrativeAgriculture, 2018, 17 (03) : 640 - 647
  • [43] THE PREVALENCE OF SIDE-EFFECTS WITH REGULAR AND SUSTAINED-RELEASE NICOTINIC-ACID
    GIBBONS, LW
    GONZALEZ, V
    GORDON, N
    GRUNDY, S
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 (04): : 378 - 385
  • [44] SALT FORMATION OF LACTIC-ACID OLIGOMERS AS MATRIX FOR SUSTAINED-RELEASE OF DRUGS
    WADA, R
    HYON, SH
    IKADA, Y
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (09) : 605 - 608
  • [45] PCEC hydrogel used on sustained-release hyaluronic acid delivery with lubrication effect
    Guo, Junde
    Li, Yue
    Lu, Hailin
    Li, Yu
    Li, Xing
    Qin, Liguo
    Dong, Guangneng
    JOURNAL OF APPLIED POLYMER SCIENCE, 2018, 135 (22)
  • [46] PHARMACOKINETICS AND INVIVO SCINTIGRAPHIC MONITORING OF A SUSTAINED-RELEASE ACETYLSALICYLIC-ACID FORMULATION
    WILSON, CG
    PARR, GD
    KENNERLEY, JW
    TAYLOR, MJ
    DAVIS, SS
    HARDY, JG
    REES, JA
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 18 (1-2) : 1 - 8
  • [47] FORMULATION AND INVITRO - INVIVO EVALUATIONS ON SUSTAINED-RELEASE ACETYLSALICYLIC-ACID TABLETS
    CAPAN, Y
    SENEL, S
    CALIS, S
    TAKKA, S
    HINCAL, AA
    PHARMAZEUTISCHE INDUSTRIE, 1989, 51 (04): : 443 - 448
  • [48] PHARMACOKINETIC EVALUATION OF NOVEL SUSTAINED-RELEASE DOSAGE FORMS OF VALPROIC ACID IN HUMANS
    BIALER, M
    FRIEDMAN, M
    DUBROVSKY, J
    RAZ, I
    ABRAMSKY, O
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1985, 6 (04) : 401 - 411
  • [49] THE EFFECT OF FOOD ON THE INVIVO BEHAVIOR OF A NOVEL SUSTAINED-RELEASE FORMULATION OF TIAPROFENIC ACID
    WILDING, IR
    DAVIS, SS
    SPARROW, RA
    BLOOR, JR
    HAYES, G
    WARD, GT
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 83 (1-3) : 155 - 161
  • [50] Epilepsy treatment with a sustained-release formulation of valproic acid - Experiences with 1172 patients
    Bergmann, A
    Schmidt, D
    Hutt, HJ
    Elger, CE
    AKTUELLE NEUROLOGIE, 1999, 26 (03) : 121 - +